Are both protein kinase A‐ and protein kinase C‐dependent pathways involved in glucagon‐like peptide‐1 action on pancreatic insulin secretion?-Reference-Cited by-同舟云学术

Are both protein kinase A‐ and protein kinase C‐dependent pathways involved in glucagon‐like peptide‐1 action on pancreatic insulin secretion?

Published:2014-04-02 Issue:4 Volume:5 Page:347-348
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Shigeto Makoto¹²,Kaku Kohei²

Affiliation:

1. Oxford Center for Diabetes, Endocrinology and Metabolism Churchill Hospital Site Headington Oxford UK

2. Department of Diabetes, Endocrinology and Metabolism Kawasaki Medical School Kurashiki Okayama Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.12225

Reference8 articles.

1. Low, but Physiological, Concentration of GLP-1 Stimulates Insulin Secretion Independent of the cAMP-Dependent Protein Kinase Pathway

2. Expression and functional activity of glucagon, glucagon‐like peptide I, and glucose‐dependent insulinotropic peptide receptors in rat pancreatic islet cells;Moens K;Diabetes,1996

3. Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid

4. Glucagon-Like Peptide-I Analogs: Effects on Insulin Secretion and Adenosine 3′,5′-Monophosphate Formation*

5. Physiological concentrations of GLP‐1 increase insulin secretion by activating protein kinase C pathway in pancreatic beta cells;Shigeto M;Diabetologia,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials;Expert Opinion on Investigational Drugs;2023-11-25

2. Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV;Drug Design, Development and Therapy;2023-11

3. New concept of the glucagon‐like peptide‐1 signaling pathway on pancreatic insulin secretion;Journal of Diabetes Investigation;2019-09-25

4. The Beneficial Effects of Switching from Dipeptidyl Peptidase-4 Inhibitors to Dulaglutide on Plasma Glucose and Hemoglobin A1c Levels: A Case Report of Four Patients with Type 2 Diabetes;YAKUGAKU ZASSHI;2018-10-01

5. A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus;Science Translational Medicine;2017-08-23